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 2 
ABSTRACT: Although nanoparticle multivalency is known to influence their biological 
labelling performance, the functional role of multivalency is largely unexplored. Here we 
show that folate receptor mediated cellular internalization mechanism of 35-50 nm 
nanoparticle shifts from caveolae- to clathrin-mediated endocytosis as the nanoparticle 
multivalency increases from 10 to 40 and results in the difference of their subcellular 
trafficking. We have synthesized folate functionalized multivalent quantum dot (QD) with 
varied average numbers of folate per QD between 10 to 110 [e.g. QD(folate)10, QD(folate)20, 
QD(folate)40, QD(folate)110] and investigated their uptake and localization into folate receptor 
over-expressed HeLa and KB cells. We found that uptake of QD(folate)10 occurs 
predominantly via caveolae-mediated endocytosis and entirely trafficked to the perinuclear 
region. In contrast, uptake of QD(folate)20 occurs via both caveolae- and chathrin-mediated 
endocytosis; uptake of QD(folate)40 and QD(folate)110 occurs predominantly via clathrin-
mediated endocytosis and these three QDs localize predominantly at lysosome with restricted 
trafficking to perinuclear region. This work shows the functional role of multivalent 
interaction in cellular endocytosis and intracellular trafficking which can be exploited for 
subcellular targeting application. 
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 3 
INTRODUCTION 
A variety of nanoparticle-based bioprobes are under development as alternative of 
molecular probes.
1-8
 These nanoprobes are bright, stable and expected to provide better 
information of biological environment.
9-11
 Common structure of nanoprobes have 
nanoparticle core, molecular/polymeric shell and covalently linked affinity biomolecule at 
their surface.
8
 The typical number of biomolecule per nanoparticle varies between < 100 to 
few hundreds.
1-8,12-16
 As a nanoprobe interacts with biological interface via affinity 
biomolecule, the nature of the interaction becomes multivalent and nanoprobe multivalency 
influences the labeling performance.
12-20
 This multivalent property of nano and larger sized 
probes (10-100 times as compared to molecular probes) offers different ways of cellular 
uptake mechanism which are highly sensitive to nanoparticle size, shape and surface 
chemistry.
7
 Literature study shows that most of the reported nanoprobes enter into cells via 
clathrin-mediated endocytosis and traffics to lysosome and raises substantial challenges in the 
development of subcellular nanoprobe.
7
 In addition, currently available synthetic approaches 
are very limited in controlling the number of attached biomolecules per nanoparticle. Thus,  
the functional role of nanoprobe multivalency toward biological labeling performance and the 
possibility of subcellular targeting via controlling this multivalency is largely unexplored.  
Multivalent and co-operative binding is common in biology that dictates the 
interaction involving biomolecules and biochemical processes.
21,22
 A similar type of 
multivalent interaction has been observed in cell-nanoparticle interaction and exploited for 
efficient biolabeling and bioimaging application.
12-20
 For example, cellular interaction and 
uptake of nanoparticle is shown to depend on the number of RGD peptide per nanoparticle 
with the maximum for 20 RGD,
13
 number of HER2 per nanoparticle with the maximum for 
11-23 HER2,
19
 number of TAT peptide per nanoparticle,
12 
number of oligonucleotide per 
nanoparticle
14
 and number of folate per nanoparticle.
18,20
 In addition, it is also observed that 
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 4 
monovalency of nanoprobes reduces their clustering on cell surface during the internalization 
processes.
15
 
Most of the reported nanobioconjugate has an uncontrolled number of biomolecules 
and it is often not clear if the observed difference in cellular interaction with nanoprobes is 
due to the nanoparticle itself or to the chemical functional group on the surface, or due to 
attached biomolecule(s).
7,8
 In addition the uptake mechanism of nanobioconjugate often 
differs from respective molecular probes and it is not clear if the nanoparticle or biomolecule 
is responsible for this difference in uptake mechanism. For example, folate receptor-mediated 
uptake of molecular probe occurs via caveolae-mediated endocytosis
23-26
 but nanoprobe 
uptake occurs via clathrin- or both clathrin- and caveolae-mediated endocytosis.
27-32
 A similar 
type of change in uptake mechanism is also observed after nanoparticle is functionalized with 
peptide,
33,34
 vitamin
35
 and antibody.
36,37
 Here we show that nanobioconjugate can switch the 
endocytosis uptake mechanism from one to another via changing their multivalency. We have 
shown that folate receptor-mediated cellular uptake mechanism of folate functionalized 
nanoparticle depends on the nanoparticle multivalency, i.e., the number of folate attached on 
nanoparticle surface. For the multivalency of < 10, the nanoprobe enters into cell via the 
caveolae-mediated endocytosis and is transported into perinuclear region – as commonly 
observed for molecular probes. As the multivalency becomes > 10, additional clathrin-
mediated endocytosis is initiated and for multivalency > 40, clathrin-mediated endocytosis 
dominates. This shifting of endocytosis mechanism from caveolae- to clathrin- maximizes the 
lysosomal trafficking of nanoprobe. This finding explains earlier reports of dominant 
clathrin-mediated endocytosis of different nanoprobes and demonstrates the importance of 
fine tuning nanoparticle multivalency in controlling the receptor-mediated endocytosis and 
their efficient subcellular targeting. 
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EXPERIMENTAL SECTION 
Materials. Cadmium oxide, tri-octyl phosphine, tri-octyl phosphine oxide, stearic 
acid, zinc stearate, sulfur powder, selenium powder, fluorescein-NHS, folic acid, N-hydroxy 
succinimide (NHS), di-cyclohexyl carbodimide, poly(ethylene glycol) methacrylate, 3-
sulfopropyl methacrylate, N,N-methylenebis(acrylamide), chlorpromazine hydrochloride, 
genistein, amiloride hydrochloride, methyl-β-cyclodextrin and folate free RPMI-1640 culture 
medium  were purchased from Sigma-Aldrich and used as received. Hoechst, lysotracker red 
were purchased from Life Technology.  
Nanoprobe Synthesis. Hydrophobic CdSe/ZnS core-shell quantum dots (QD) with 
red emission were synthesized using reported method.
8
 These QDs were then transformed 
into hydrophilic nanoparticles via polyacrylate coating by our reported method.
8
 In brief, 
hydrophobic QD was dissolved in 10 mL igepal-cyclohexane reverse micelle solution and 
mixed with aqueous solution of acrylate monomers. We have used N-(3-aminopropyl)-
methacrylamide hydrochloride that provide primary amine functional group, 3-
sulfopropropyl methacrylate that provide anionic charge, poly (ethylene glycol) methacrylate 
that provide polyethyleneglycol functionality and bis [2-(methacryloyloxy) ethyl] phosphate 
that function as cross-linker. The optically clear solution was purged with nitrogen and mixed 
with tetramethyl ethylenediamine and aqueous solution of ammonium persulphate to initiate 
the polymerization. The reaction was continued for one hour and then ethanol was added to 
quench the reaction. Precipitated QD was washed with chloroform and ethanol and finally 
dispersed in double distilled water. This process produces polyacrylate coated QD of 30-40 
nm hydrodynamic diameters and with ~ 125 average number of primary amine per QD. 
Next, folate functionalized QD was synthesized via competitive bioconjugation 
method reported earlier.
20
 In brief, polyacrylate coated QD was reacted with a mixture of 
NHS-folate and NHS-fluorescein with varying molar ratio. Under this condition two NHS 
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 6 
reagents competes for reaction with primary amines present on QD surface and the number of 
folate bound to QD would depends on mole of NHS-folate. The reaction was continued for 
overnight and finally the solution was dialyzed to remove unbound reagents. Following this 
approach the number of folate per QD has been varied between 10 to 110, and results are 
summarized in Table 1. 
Estimation of Number of Folate per QD. Number of folic acid per QD was 
estimated by our reported method.
20
 In brief, concentration of QD was measured by using 
molar extinction coefficient of QD. Next, folate functionalized QD samples were treated with 
HCl to dissolve the QD and neutralized by adding NaOH. Then concentration of folate and 
fluorescein were determined by measuring the fluorescence intensity of folate and 
fluorescein. Finally, number of folate per QD was calculated from the ratio of concentration 
of folate and the concentration of QD. 
Cell Labeling Study. Human cervical cancer cell line HeLa and KB cells were used 
as positive folate receptor cells. Cells were cultured in folate free RPMI-1640 (Invitrogen) 
with 10% heat activated fetal bovine serum (FBS) and 1% penicillin streptomycin at 37 
°
C 
and 5 % CO2 atmosphere. Cells were cultured overnight in a 24-well plate with 500 µL 
medium and then 30 µL QD sample was added followed by 1-3 hrs incubation. Next, cells 
were washed with PBS buffer solution and washed cells were used for imaging study or 
further incubated with fresh medium for 1-24 hrs followed by imaging study. Control cell 
labeling experiments were performed by adding free folic acid (100 µg/mL) in culture 
medium and by incubating cells at 4 
°
C.  
Co-Localization Study. Cells were cultured in a 24 well plates for 24 hours in folate 
free RPMI medium. Cells were incubated with QD samples for 3 hrs for their uptake by cells. 
Next, cells were washed with PBS buffer and fresh medium was added and kept for the next 
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 7 
12 hrs. Next, cells were incubated with lysotracker red for 15 mins and washed cells were 
used for imaging study. 
Endocytosis Inhibition Study. For the endocytosis mechanism study, cells were 
taken in folate free RPMI medium and incubated with an inhibitor of desired concentration 
for one hour. Next, 30 µL QD sample was added and mix was further incubated for 1-2 hrs. 
The cells were then washed with PBS buffer for two times to remove unbound QD from the 
cell surface and used for imaging. For quantitative measurement cells were treated with 100 
µL trypsin-EDTA for 2 mins and detached cells were isolated by centrifuge. Finally, cells 
were dispersed in PBS buffer and used for Flow Cytometric, fluorescence and ICP 
measurements. Typically, 200 µL of QD labeled dispersed cells of 0.1-0.5 millions were used 
for these studies and for ICP measurements cells were digested in 10% suprapure (ICP grade) 
HNO3 . 
Instrumentation. UV-visible absorption spectral studies were carried out with a 
Shimadzu UV-2550 UV-visible spectrophotometer.  The DLS size and zeta potential were 
measured by Malvern Nano ZS instrument. Transmission electron microscopic (TEM) study 
was carried out using FEI Tecnai G2 F20 microscope. Flow Cytometry was performed using 
BD Accuri C6 Flow Cytometer, fluorescence-based quantification was performed using 
Synergy Mx monochromator based multimode fluorescence microplate reader (BioTek) and 
ICP-based quantification was performed using Optima 2100DV inductively coupled plasma 
atomic emission spectroscopy (ICP-AES, Perkin Elmer). Fluorescence image of cells were 
captured by Olympus IX 81 microscope using image-pro plus version 7.0 software and Carl 
Zeiss Apotome Imager Z1 microscope.  
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 8 
RESULTS  
Synthesis of Folate Functionalized Nanoparticle of Varied Multivalency. Folate 
functionalized nanoparticle with a varied number of folate per nanoparticle was synthesized 
using our reported method.
20
 In first step hydrophobic quantum dot (QD) is transformed into 
polyacrylate coated QD with low number (typically ~125) of surface terminated primary 
amines. Polyacrylate shell of these QD is made of polyethylene glycol (PEG) and appropriate 
ratio of amines and sulfates so that non-specific interaction with cell is minimum and 
nanoparticle has insignificant uptake by HeLa/KB cells unless functionalized with folate.
20 
Next, primary amines are reacted with N-hydroxysuccinamide (NHS) derivative of folic acid 
(NHS-folate) for the preparation of folate functionalized QD. The number of attached folate 
per QD was controlled between 10-110 via competitive bioconjugation method.
20
 In brief, 
amine functionalized QD is reacted with mixture of NHS-folate and NHS-fluorescein with 
their varied molar ratio, where the number of folate attached to QD depends on the molar 
ratio of NHS-folate used. Next, excess reagents are removed by dialysis and number of folate 
per QD is determined by using the fluorescence property of QD, folate and fluorescein.
20
 In 
particular, we have synthesized folate functionalized QD with variable multivalency such as 
QD(folate)10, QD(folate)20, QD(folate)40 and QD(folate)110.(Scheme 1) Characterization of 
these functional QDs is shown in Figure 1, Supporting Information, Table S1, Figure S1, S2 
and details of their properties are summarized in Table 1. All these particles have QD core 
and polyacrylate shell with overall hydrodynamic size of 35-50 nm and anionic surface 
charge.  
Nanoparticle Multivalency Effects in Cell Uptake Mechanism and Subcellular 
Trafficking of Nanoparticle. Next, we study the uptake of functional QD by folate receptor 
over-expressed HeLa and KB cells. Results are summarized in Figure 2-7, Table 1 and 
Supporting Information, Figure S3-S14. Three types of control experiments have been 
Page 8 of 34
ACS Paragon Plus Environment
The Journal of Physical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 9 
performed to confirm the folate receptor based selective labelling. In the first control 
experiment labelling is performed using QD without folate functionalization. (see Supporting 
Information, Figure S3) Results show that QD cannot label HeLa and KB cells when they are 
not functionalized with folate. In second control experiment folate functionalized QD is used 
for the labelling of cells that do not have over-expressed folate receptors and results show 
that QD cannot label such cells.
20
 In third control experiment no labelling of folate 
functionalized QD is observed in presence of free folic acid in the cell culture medium. 
(Supporting Information, Figure S4) These results confirm selective labelling and uptake of 
folate functionalized QD by cells having over expressed folate receptors. It is know that 
proteins from culture media may adsorb on the nanoparticle surfaces and thus cells may not 
see the folate functionalization.
38
 In order to understand this issue we have measured the 
hydrodynamic size and surface charges of the folate functionalized nanoparticles in serum 
containing and serum free cell culture media. We found that there is no significant change in 
their hydrodynamic size and surface charges. (Supporting Information, Table S1 and Figure 
S1) In addition we have also studied uptake of QD(folate)10 and QD(folate)110 in serum free 
cell culture media. We have not seen any significant difference on their cell uptake. 
(Supporting Information, Figure S5) These results conclude that proteins have poor binding 
with QD surface and QD interacts with cell using folic acid. This result is expected as our 
nanoparticles are coated with polyethylene glycol (PEG) that is known to reduce the non-
specific interactions. 
Energy dependent internalization of these QDs has been confirmed by incubating the 
HeLa cells with folate functionalized nanoparticles at 4 
°
C. Reduced cellular uptake confirms 
energy dependent endocytosis mechanism (Supporting Information, Figure S6) Mechanism 
of cellular uptake has been investigated using various inhibitors that are known to hinder 
different endocytosis mechanism. We have used chlorpromazine (CHP) that blocks clathrin-
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 10
mediated endocytosis, amiloride that block macropinocytosis, genistein (GEN) that block 
caveolae-mediated endocytosis and methyl-β-cyclodextrin (MBCD) that blocks lipid raft-
mediated endocytosis. Typically, cells are taken in folate free culture medium, incubated with 
inhibitors of desired concentration for one hour followed by incubation with QD samples. 
(see Supporting Information, Table S2 for details). Next, labeling of QD is thoroughly 
investigated and quantified. Results clearly show that all the QD samples have high labeling 
and cell uptake in absence of any inhibitors. However, in presence of inhibitors they behave 
differently. Results of HeLa cells are shown in Figure 2, Figure 3 and Supporting Information 
Figure S7. Although amiloride and MBCD hardly affect labeling property of all the QD, CHP 
and GEN are observed to influence the QD labeling depending on multivalency. In particular 
GEN completely inhibits QD(folate)10 uptake and significantly inhibits QD(folate)20 uptake. 
In contrast CHP significantly inhibit uptake of QD(folate)20, QD(folate)40 and QD(folate)110. 
However, uptake inhibition of QD(folate)10 by CHP is very insignificant.   
Inhibitor induced differential QD uptake has been quantified by three different 
approaches such as cadmium estimation via inductively coupled plasma atomic emission 
spectroscopy (ICP-AES), QD fluorescence measurement using fluorescence plate reader and 
QD fluorescence measurement using flow cytometry. Figure 3 summarizes the results of 
three methods in HeLa cells and they reasonably furnish similar conclusions and corroborate 
with fluorescence imaging results shown in Figure 2. All the results clearly show that 
QD(folate)10 uptake is almost completely inhibited by GEN, slightly inhibited by CHP and 
other inhibitors are unable to hinder their uptake. In contrast, the uptake of QD(folate)20 is 
predominantly inhibited by both GEN and CHP but amiloride/MBCD are unable to prevent 
their uptake. The uptake of QD(folate)40 and QD(folate)110 are inhibited significantly by CHP, 
only slightly inhibited by GEN and almost unaffected by amiloride/MBCD. These results 
clearly suggest that uptake of QD(folate)10 occurs predominantly via caveolae-mediated 
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 11
endocytosis but uptake of QD(folate)40 and QD(folate)110 occurs predominantly via clathrin-
mediated endocytosis and uptake of QD(folate)20 occurs via both clathrin- and caveolae-
mediated endocytosis. 
Similar type multivalency dependent QD uptake is also observed in KB cells. (Figure 
4, Supporting Information, Figure S8) In this case we have used three additional inhibitors 
such as nystatin
25
 which inhibits the caveolae mediated endocytosis, sucrose
27 
which inhibits 
clathrin mediated endocytosis and cytochalasin-D
34
 (cyto-D) which inhibits 
macropinocytosis. Cell imaging study shows that amiloride, cyto-D, and MBCD hardly affect 
labeling property of all QD but GEN and nystatin significantly inhibits QD(folate)10 uptake 
and CHP and sucrose significantly inhibit QD(folate)110 uptake. (Supporting Information, 
Figure S8) Flow cytometry based quantification study shows that QD(folate)10 uptake is 
almost completely inhibited by GEN and nystatin, partially inhibited by MBCD but 
amiloride/CHP/cyto-D/sucrose is unable to hinder their uptake. (Figure 4) In contrast, the 
uptake of QD(folate)110 is predominantly inhibited by CHP and sucrose, partially inhibited by 
GEN and amiloride/MBCD/cyto-D/nystatin is unable to prevent their uptake. These results 
suggest that KB cell also follow same trend as of HeLa cell, i.e. entry of lower valent 
QD(folate)10 occurs predominantly via caveolae mediated endocytosis but entry of higher 
valent QD(folate)110 occurs predominantly via clathrin-mediated endocytosis. In addition we 
have used mixture of two inhibitors (CHP and amiloride) and found no significant changes on 
their uptake. (Figure 4 and Supporting Information, Figure S8) 
Another control experiment has been performed to investigate the uptake of 
QD(folate)110 in presence of both endocytosis inhibitors CHP and GEN together. (Supporting 
Information, Figure S9) The result shows that uptake of QD(folate)110 is totally inhibited in 
presence of CHP and GEN together. In contrast uptake of QD(folate)110 is not completely 
inhibited in presence of CHP only. This result indicates that both clathrin- and caveolae-
Page 11 of 34
ACS Paragon Plus Environment
The Journal of Physical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 12
mediated endocytosis are operative for QD(folate)110 but  clathrin-mediated endocytosis 
dominates in normal condition and once CHP is added to block the clathrin-mediated 
endocytosis, the caveolae-mediated endocytosis becomes operative.  
We have also observed multivalency dependent subcellular localization of QD 
nanoprobe. (Figure 5) This study is performed by incubating QD samples with KB cells, 
followed by washing to remove unbound particles and observing the localization of 
endocytosized QD for next 24 hrs. It is observed that QD(folate)10 is trafficked to perinuclear 
region and concentrate at one side of the nucleus. High magnification fluorescence images of 
nuclear probe and QD(folate)10 labeled cells at different Z planes shows that QDs localizes at 
the same plane of the nucleus and merged image shows that QD(folate)10 localizes at the 
perinuclear region. (Supporting Information, Figure S10 and Figure S11)  In contrast all other 
QDs fail to localize at perinuclear region. Further colocalization study with lysotracker red 
suggests that QD(folate)40 and QD(folate)110  are predominantly trafficked to lysosome within 
12 hrs. (Figure 6 and Supporting Information, Figure S12) High magnification fluorescence 
images of lysotracker red and QD(folate)110 labeled cells also confirm that higher multivalent 
QDs are localized at lysosome. (Figure 6) Subcellular localization of QD(folate)10 is followed 
at different time point via colocalization study with lysotracker red and results show that 
QD(folate)10 never localize with lysotracker red before trafficking to perinuclear 
region.(Supporting Information, Figure S13) This might be linked to their caveolae-mediated 
endocytosis where caveosome never fuse with lysosome and viruses usually choose caveolae 
mediated endocytosis to escape their lysosomal degradation.
39-42
 
Control subcellular localization experiment has also been studied in presence of 
endocytosis inhibitors that significantly inhibits the QD uptake. In particular it has been 
observed that the lysosomal trafficking of higher multivalent QD can be redirected to 
perinuclear trafficking if clathrin-mediated endocytosis is blocked by CHP. A representative 
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result is provided in Figure 7. It shows that usual lysosomal trafficking of QD(folate)110 can 
be successfully redirected towards perinuclear region if their clathrin mediated uptake is 
blocked by CHP. This result further suggests that caveolae-mediated uptake is suppressed by 
clathrin-mediated uptake in a higher multivalent QD but it can be operative under appropriate 
condition. 
It is known that the kinetics of clathrin- mediated endocytosis is very fast as compared 
to caveolae- mediated endocytosis. We have performed additional control experiments to 
investigate the uptake kinetics of different QD with respect to the multivalency dependent 
shifting of endocytosis mechanism. It is found that QD(folate)110 has relatively faster uptake 
rate than QD(folate)10. (Supporting Information, Figure S14) We found that uptake of 
QD(folate)110 is higher than QD(folate)10 in one hour incubation. We also found that 
QD(folate)110 colocalize with lysotracker red within 12 hrs. In contrast QD(folate)10 takes 24 
hrs to localize at perinuclear region. This result suggests that faster kinetics of clathrin-
mediated endocytosis can suppress the slower caveolae-mediated endocytosis, even if the 
latter is partially operative. This mechanism can also explain perinuclear targeting of all QD 
in presence of CHP that blocks clathrin-mediated endocytosis.  
 
DISCUSSION 
Nanoparticle based probes are emerging alternative of molecular probes.
1,4
 However, 
development of subcellular imaging nanoprobes is very challenging. Here we have designed 
nanoprobe with controlled multivalency, typically in the range of 10-100 in order to 
investigate their influence on biolabeling performances. Currently available synthetic 
approaches have limitations in controlling this multivalency and most of the reported 
nanoprobe/nanobioconjugate has multivalency of few hundreds.
7,8
 Here we show that cell 
uptake mechanism and subcellular trafficking depends on nanoparticle multivalency. In 
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particular we have shown that high multivalency leads to clathrin-mediated endocytosis and 
lysosomal trafficking of nanoprobe that restricts their subcellular targeting. In contrast, 
nanoprobe having lower multivalency (typically < 10) enters into cell via caveolae-mediated 
endocytosis and localized to perinuclear region without trafficking at lysosome. The 
transition between clathrin- and caveolae- occurs typically in the multivalency range of 10-40 
and thus nanoprobe multivalency in this range need to be carefully investigated. 
The observed nanoprobe multivalency dependent cell uptake mechanism has special 
significance for subcellular targeting applications. It is well known that nature of endocytosis 
dictates the trafficking mechanism and subcellular localization of foreign materials.
39,41
 For                                                                                                    
example, caveolae- and lipid raft-mediated endocytosis traffics materials through caveosome 
with lower chances of degradation because of  neutral pH of caveosome.
43,44
 Thus caveolae- 
and lipid raft-mediated endocytosis leads to efficient perinuclear trafficking of material, 
particularly to nucleus, endoplasmic reticulum and Golgi apparatus.
40,43
 In contrast, clathrin-
mediated endocytosis traffics the material to acidic endosomal/lysosomal compartments.
  
In 
drug or gene delivery approach it is preferable that the nanoparticle does not traffic to 
lysosome where they can be degraded.
43,45,46
 Thus preferential caveolae- and lipid raft-
mediated endocytosis over clathrin-mediated endocytosis have enormous importance. 
However, this type of specific endocytosis remains a challenging issue and in reality clathrin-
mediated endocytosis becomes most dominating pathway for nanoparticle, inhibiting their 
subcellular targeting.
47-53
 Here we show that lowering of nanoparticle multivalency greatly 
enhances their subcellular targeting performance with minimum lysosomal trapping via 
modified uptake mechanism.  
Presented results are based on enodocytosis of folic acid functionalized nanoparticle 
by folate receptor. Folate receptor is over-expressed in several types of cancer cells.
54
 It is a 
GPI linked anchor protein that diffusely distributes on cell membrane and concentrate in 
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small flask shaped membrane invagination called caveolae.
26
 The folate receptor is 
colocalized with caveolin which is an integral part of caveloae. It is known that clustering of 
GPI-anchored proteins regulate their sequestration in caveolae and promotes caveolae-
mediated endocytosis. So, high concentration of folate bound receptors in caveolae is 
required for folate transport.
55 
Thus it is expected that folate receptor mediated uptake of 
nanoparticle is linked to the clustering property of folate receptors by nanoparticle.
26 
In 
particular
 
nanoparticle with varied multivalency can induce different extent of clustering of 
folate receptor and thus expected to modulate the endocytosis mechanism. Similar type of 
nanoparticle multivalency directed interaction is expected for nanoparticle functionalized 
with RGD peptide,
13
 HER2,
19
 TAT peptide
12 
and
 
oligonucleotide.
14
  
Based on our result a mechanism is proposed to explain the role of nanoparticle 
multivalency in dictating the folate receptor-mediated cell uptake mechanism and in 
controlling the caveolae- vs clathrin-mediated endocytosis. (Scheme 2) Low multivalency 
(typically < 10) offers modular interaction of nanoparticle with cell surface receptors and 
directs the nanoprobe toward the caveolae. This event leads to the clustering of folate 
receptors followed by caveolae-mediated endocytosis. In contrast high multivalency 
(typically > 20) of nanoparticle can cause receptors to cluster on the cell surface via cross-
linking.
26
 Stronger binding of nanoprobe with cell surface via multiple receptors reduces the 
receptor mobility
15 
and restricts nanoparticle localization at a fixed position of membrane and 
initiates additional signaling pathway for clathrin-mediated endocytosis. The faster kinetic of 
clathrin-mediated endocytosis over caveloae-mediated endocytosis leads the domination of 
clathrin-mediated endocytosis. When CHP is used to block the clathrin-mediated endocytosis 
(via binding with clathrin protein) the suppressed caveolae-mediated endocytosis becomes 
operative again. 
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Proposed mechanism can explain anomalies observed in folate receptor mediated 
endocytosis. Earlier work shows that uptake of folate functionalized protein, polymer, micelle 
and nanoparticle occurs by cavevolae- or clathrin-mediated endocytosis. For example, folate 
functionalized BSA/dextran (with 1-3 folate per polymer)
23,25
 or liposome (with 365 folate 
per particle) enter into folate over-expressed KB cell via caveolae mediated endocytosis.
24
 In 
contrast, folate functionalized silica particle and carbon nanotube (with uncontrolled number 
of folate per particle) enter into KB and HeLa cell via clathrin mediated endocytosis.
27,28
 
Folate functionalized polymer micelle enter into HeLa/KB/MCF-7 cell via both clathrin and 
caveolae mediated endocytosis.
30-32
 There is also reports on change in uptake mechanism 
depending on particle size
30
 or folate density,
32
 surface chemistry,
27
 role of folate 
multivalency on rate of endocytosis
56
 and role of special arrangement of folate on in vivo 
targeting efficiency.
57
  
Here we show the effect of folate multivalency on folate receptor mediated 
endocytosis mechanism and subcellular trafficking. In particular the proposed mechanism can 
explain the clathrin-mediated endocytosis often observed by folate functionalized 
nanoparticle. Proposed mechanism shows that higher multivalency and faster kinetics of 
clathrin-mediated endocytosis can induce preferential clathrin-mediate endocytosis. As 
commonly used nanoparticles have high multivalency, they often mask the caveolae-
mediated endocytosis of folate functionalized nanoparticle.  
 
CONCLUSION 
We have shown that cell uptake mechanism of nanoparticle can be controlled by 
changing their multivalency, typically between 10-40. We have synthesized folate 
functionalized QD nanoprobe with varied multivalency and found that folate receptor 
mediated cellular internalization mechanism of QD shifts from caveolae- to clathrin-mediated 
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endocytosis, as the nanoparticle multivalency increases from 10 to 40. While caveolae-
mediated uptake traffics nanoprobe into perinuclear region, chathrin-mediated endocytosis 
traffics them to lysosome. This work shows the importance of lower multivalency (typically 
< 10) of nanoparticle for efficient subcellular targeting and established the functional role of 
multivalent interaction in cellular endocytosis. Further study should be directed to prepare 
appropriate nanobioconjugate with lower multivalency for efficient subcellular targeting. 
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Table 1: Composition, Property, Uptake Mechanism and Sub-Cellular Localization of 
Nanobioconjugates Used in this Study 
NHS-
folate
(mole%)
Number 
of 
folate/QD
DLS 
size 
(nm)
Charge 
(mV)
Abbreviation Cell uptake 
pathway
Sub-cellular 
localization
5
18
25
95
10±4
20±5
40±7
110±10
̴ 35-40
̴ 40-45
̴ 45-50
̴ 45-50
-20
-20
-17
-14
QD(folate)10
QD(folate)20
QD(folate)40
QD(folate)110
caveolae
caveolae and 
clathrin
clathrin
clathrin
perinuclear region
perinuclear region 
and lysosome
lysosome
lysosome
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Scheme 1. Synthetic approach for the preparation of folate functionalized quantum dot (QD). 
Polyacrylate coated QD with ~125 primary amine per QD is reacted with mixture of NHS-
folate and NHS-fluorescein of varied molar ratio for the preparation of QD(folate)10, 
QD(folate)20, QD(folate)40 and QD(folate)110. 
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Figure 1. Absorption (a) and emission spectra (b) of QD samples used in this study. 
Concentrations of QD are normalized by maintaining same absorbance at 590 nm and 
emission spectra are obtained after dissolving QD by HCl addition followed by neutralizing 
with NaOH. Variation of folate and fluorescein are evident from the change of emission band 
intensity of folate/fluorescein. 
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Figure 2. Fluorescence image of HeLa cells labelled with QD(folate)10, QD(folate)20, 
QD(folate)40 and QD(folate)110 in presence of different endocytosis inhibitors. Red color 
corresponds to QD and blue color corresponds to nuclear probe. Typically, cells are 
incubated with inhibitors followed by incubation with QD samples and then washed cells are 
imaged under fluorescence microscope. Images show that QD(folate)10 uptake is 
predominantly inhibited by GEN only, QD(folate)20 uptake is inhibited by both GEN and 
CHP but QD(folate)40 and QD(folate)110 uptake is  significantly inhibited only by CHP. Scale 
bar represents 50 µm. 
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Figure 3. Quantitative estimation of QD uptake in HeLa cells in presence of different 
endocytosis inhibitors, using cadmium estimation via ICP (a), QD fluorescence measurement 
using flow cytometer (b) and QD fluorescence measurement using fluorescence plate reader 
(c). Typically, cells are incubated with inhibitors followed by incubation with different QD 
samples and then washed cells are used for quantifications. Three methods clearly show that 
QD(folate)10 uptake is inhibited by GEN, QD(folate)20 uptake is inhibited by both GEN and 
CHP but uptake of QD(folate)40 and QD(folate)110 is inhibited by CHP.   
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Figure 4. Flow cytometry based quantitative analysis of uptake of QD(folate)10 (a,c) and 
QD(folate)110 (b,d) in KB cells in presence of different endocytosis inhibitors. Result shows 
that QD(folate)10 uptake is primarily inhibited by GEN and nystatin but uptake of 
QD(folate)110 is primarily inhibited by CHP and sucrose. 
 
 
 
 
 
Page 29 of 34
ACS Paragon Plus Environment
The Journal of Physical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 30
QD(folate)10
24 hrs
BF
BF
QD(folate)110
QD(folate)10
F
QD(folate)110
F
 
Figure 5. Subcellular localization of QD(folate)10 and QD(folate)110 in KB cells, showing 
that lowering of multivalency enhances the perinuclear targeting performance. QDs are 
incubated with cells for 3 hrs and washed cells are mixed with fresh culture medium for 
another 24 hrs before imaging under bright field (BF) or fluorescence (F) mode. Red color 
corresponds to QD and blue color corresponds to nuclear probe. Scale bar represents 50 µm. 
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Figure 6. Low and high magnification fluorescence image of QD(folate)110 and lysotraker 
labelled HeLa cells. Here cells are incubated with sample for 3 hrs and washed cells are 
further treated with media for next 12 hrs for imaging. Red color corresponds to lysotracker, 
green color corresponds to QD and yellow color in merged image indicates the 
colocalization. Scale bar represents 20 µm.  
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Figure 7. Change in subcellular localization of QD(folate)110 in presence of CHP inhibitor. 
KB cell is first incubated with CHP followed by incubation with QD(folate)110 and washed 
cells are mixed with fresh culture medium for another 24 hrs before imaging under bright 
field (BF) or fluorescence (F) mode. Red color corresponds to QD and blue color corresponds 
to nuclear probe. Merged fluorescence image indicates perinuclear localization of 
QD(folate)110. Scale bar represents 50 µm. 
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Scheme 2. Proposed endocytosis mechanism of nanoprobe with low and high multivalency. 
Low multivalency offers modular interaction with cell surface receptors that directs the 
nanoprobe toward caveolae and promotes caveolae-mediated endocytosis. In contrast, high 
multivalency offers strong binding of nanoprobe with cell surface via multiple receptors and 
induce signaling pathway for clathrin-mediated rapid endocytosis. 
 
Page 33 of 34
ACS Paragon Plus Environment
The Journal of Physical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 34
 
TOC IMAGE 
 
blue- nuclear probe, red- nanoprobe
caveolae mediated
endocytosis
clathrin mediated
endocytosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 34 of 34
ACS Paragon Plus Environment
The Journal of Physical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
